{"id":"NCT02279732","sponsor":"Bristol-Myers Squibb","briefTitle":"Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin","officialTitle":"A Randomized, Multicenter, Double-Blind, Multinational, Phase 3 Trial Comparing the Efficacy of Ipilimumab in Addition to Paclitaxel and Carboplatin Versus Placebo in Addition to Paclitaxel and Carboplatin in Subjects With Stage IV/Recurrent Non-Small Cell Lung Cancer (NSCLC) With Squamous Histology","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-13","primaryCompletion":"2018-05-03","completion":"2018-05-03","firstPosted":"2014-10-31","resultsPosted":"2019-08-28","lastUpdate":"2019-08-28"},"enrollment":342,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lung Cancer (NSCLC)"],"interventions":[{"type":"BIOLOGICAL","name":"Paclitaxel","otherNames":["Taxol®","BMS-181339"]},{"type":"BIOLOGICAL","name":"Carboplatin","otherNames":["Paraplatin®"]},{"type":"BIOLOGICAL","name":"Ipilimumab","otherNames":["MDX-010","BMS-734016"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Arm 1: Carboplatin + Paclitaxel + Ipilimumab","type":"EXPERIMENTAL"},{"label":"Arm 2: Carboplatin + Paclitaxel + Placebo","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to determine whether Ipilimumab plus Paclitaxel and Carboplatin will extend the life of patients with squamous only non small cell lung cancer more than placebo plus Paclitaxel and Carboplatin.","primaryOutcome":{"measure":"Overall Survival (OS) of All Randomized Participants Who Received at Least One Dose of Blinded Study Therapy","timeFrame":"Approximately 43 months post study start","effectByArm":[{"arm":"Ipi + PAC/CAR","deltaMin":null,"sd":null},{"arm":"Placebo + PAC/CAR","deltaMin":null,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":49,"countries":["China","Germany","Hungary","Poland","Singapore","South Korea"]},"refs":{"pmids":[],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","http://bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":40,"n":98},"commonTop":["Neutropenia","Leukopenia","Anaemia","Haemoglobin decreased","Thrombocytopenia"]}}